Document is current
Any future updates will be listed below
-
Authors
Zhang, Peng
Narayanan, Elisabeth https://orcid.org/0000-0001-8836-181X
Liu, Qingbo https://orcid.org/0000-0002-1347-6636
Tsybovsky, Yaroslav
Boswell, Kristin
Ding, Shilei
Hu, Zonghui
Follmann, Dean
Lin, Yin
Miao, Huiyi
Schmeisser, Hana
Rogers, Denise
Falcone, Samantha
Elbashir, Sayda M.
Presnyak, Vladimir
Bahl, Kapil
Prabhakaran, Madhu
Chen, Xuejun https://orcid.org/0000-0001-9192-0440
Sarfo, Edward K. https://orcid.org/0000-0001-9015-3446
Ambrozak, David R.
Gautam, Rajeev
Martin, Malcom A.
Swerczek, Joanna
Herbert, Richard
Weiss, Deborah
Misamore, Johnathan
Ciaramella, Giuseppe
Himansu, Sunny https://orcid.org/0000-0002-7954-9674
Stewart-Jones, Guillaume
McDermott, Adrian https://orcid.org/0000-0003-0616-9117
Koup, Richard A.
Mascola, John R.
Finzi, Andrés
Carfi, Andrea
Fauci, Anthony S.
Lusso, Paolo https://orcid.org/0000-0002-2813-4081
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (n/a, n/a)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (n/a)
Frederick National Laboratory for Cancer Research (Contract HHSN261200800001)
- License Information
-
More Information
Article History
Received: 9 June 2021
Accepted: 6 October 2021
First Online: 9 December 2021
Competing interests
: P.L., P.Z., and E.N. are named on a HIV RNA Vaccine patent (PCT/US2020/022710). E.N., S.F., S.M.E., V.P., K.B., S.H., G.S.-J. and A.C. are employees of Moderna Inc. and hold equities from the company. All other authors have no competing interests.
